The Procter & Gamble Company
PGLast close · Oct 16, 2026159.31+2.23 (+1.42%)
Market cap$370.0B
5 firms' latest targets, last 90 days: median $152.00 ($149.00–$166.00), 5% below the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-06 | RBC Capital | $166.00 | ▼ 1% | +4% |
| 2026-10-06 | Evercore ISI | $166.00 | ▲ 2% | +4% |
| 2026-08-24 | Bernstein | $149.00 | ▼ 4% | -6% |
| 2026-07-30 | HSBC | $149.00 | ▲ 5% | -6% |
| 2026-07-21 | Barclays | $152.00 | ▲ 4% | -5% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2024reported | $84.0B | +2% | $6.02 | +2% | est. $83.9B+0% | est. $5.95 | 7 |
| 2025reported | $84.3B | +0% | $6.51 | +8% | est. $84.2B+0% | est. $6.78 | 14 |
| 2026reported | $87.0B | +3% | $6.62 | +2% | est. $87.1B+0% | est. $6.88 | 18 |
| 2027 | $88.8B | +2% | $6.97 | +1% | $88.1B–$89.3B | $6.90–$7.03 | 18 |
| 2028 | $91.3B | +3% | $7.39 | +6% | $90.0B–$92.5B | $7.22–$7.47 | 18 |
| 2029 | $94.5B | +3% | $7.80 | +6% | $91.2B–$96.0B | $7.24–$8.16 | 14 |
| 2030 | $97.6B | +3% | $8.00 | +3% | $96.0B–$99.2B | $7.84–$8.17 | 13 |
| 2031 | $94.2B | -3% | $7.37 | -8% | $92.7B–$95.7B | $7.22–$7.53 | 6 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.